 |
|
Clinical Correlates of Alzheimer's Disease With and Without Silent Radiographic Abnormalities
Karen Marder, MD, MPH;
Marcus Richards, PhD;
Jacqueline Bello, MD;
Karen Bell, MD;
Mary Sano, PhD;
Lisa Miller;
Marshal Folstein, MD;
Marilyn Albert;
Yaakov Stern, PhD
Arch Neurol. 1995;52(2):146-151.
Abstract
| |
Objective
To determine whether patients with Alzheimer's disease (AD) who do not have historical or clinical evidence of stroke but who do have computed tomographic or magnetic resonance imaging evidence of noncortical lesions smaller than 2 cm or periventricular "caps" differ from other patients with AD.
Methods
The computed tomographic or magnetic resonance imaging scans of 158 patients meeting criteria of the National Institute of Neurological Disorders and Stroke—Alzheimer's Disease and Related Disorders Association for probable AD were reviewed by one neuroradiologist. Two measures of disease severity—the Modified Mini-Mental State examination and the Blessed Dementia Rating Scale (Part I)—were subjected to two-way analysis of variance with scan type (computed tomography or magnetic resonance imaging) and lesion number as between-group factors and age and disease duration as covariates.
Results
No relationship was seen between lesion number or periventricular caps and disease severity.
Conclusion
In this cross-sectional analysis using these clinical measures, patients with AD who have well-defined radiographic abnormalities cannot be differentiated from patients with AD who do not have them.
Author Affiliations
From the Departments of Neurology (Drs Marder, Richards, Bell, Sano, and Stern and Ms Miller), Psychiatry (Dr Stern), the H. Sergievsky Center (Drs Marder, Richards, and Stern), and The Center for Alzheimer's Disease Research (Drs Marder, Bell, Sano, and Stern), College of Physicians and Surgeons, Columbia University, New York, NY; the Division of Neuroradiology, Albert Einstein College of Medicine, Bronx, NY (Dr Bello); the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Md (Dr Folstein); and the Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Mass (Dr Albert).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Subcortical Hyperintensities in Alzheimer's Disease: Associated Clinical and Metabolic Findings
Sultzer et al.
J. Neuropsychiatry Clin. Neurosi. 2002;14:262-269.
ABSTRACT
| FULL TEXT
Diffusion and Perfusion MR Imaging in Cases of Alzheimer's Disease: Correlations with Cortical Atrophy and Lesion Load
Bozzao et al.
Am. J. Neuroradiol. 2001;22:1030-1036.
ABSTRACT
| FULL TEXT
Neuropsychiatric Significance of Subcortical Hyperintensity
Campbell and Coffey
J. Neuropsychiatry Clin. Neurosi. 2001;13:261-288.
FULL TEXT
Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I
Lopez et al.
Neurology 2000;55:1854-1862.
ABSTRACT
| FULL TEXT
Does APO epsilon 4 correlate with MRI changes in Alzheimer's disease?
Doody et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:668-671.
ABSTRACT
| FULL TEXT
Impact of White Matter Changes on Clinical Manifestation of Alzheimer's Disease : A Quantitative Study
Hirono et al.
Stroke 2000;31:2182-2188.
ABSTRACT
| FULL TEXT
Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease
Starkstein et al.
J. Neurol. Neurosurg. Psychiatry 1997;63:66-73.
ABSTRACT
| FULL TEXT
|
